J. Muntane et al., IRON-METABOLISM AND OXIDATIVE STRESS DURING ACUTE AND CHRONIC PHASES OF EXPERIMENTAL INFLAMMATION - EFFECT OF IRON-DEXTRAN AND DEFEROXAMINE, The Journal of laboratory and clinical medicine, 126(5), 1995, pp. 435-443
Citations number
50
Categorie Soggetti
Medical Laboratory Technology","Medicine, General & Internal
Iron overload induces a rise in lipid peroxidation, but there are no d
ata on the effects of iron administered in vivo on the production of f
ree radicals by inflammatory cells. Further, there is lack of agreemen
t about the benefits of deferoxamine (Dfx) in the treatment of anemia
and oxidative stress during inflammation and chronic diseases, In this
study, iron-dextran (Fe-dextran) or Dfx was administered subcutaneous
ly during the acute and chronic phases of carrageenan-induced granulom
a, Several parameters related to iron metabolism, inflammatory cell ac
tivity, and lipid peroxidation were measured in liver, plasma, and the
inflammatory exudate, Treatment with Fe-dextran increased iron conten
t in plasma and in stores, increased production of superoxide anion (O
-2(-)) by inflammatory cells and lipid peroxidation, and also altered
the inflammatory process, Dfx mobilized iron from stores without modif
ying essential parameters related to anemia or to the level of lipid p
eroxidation induced by inflammation, We conclude that treatment with F
edextran had a beneficial effect on recovery from the anemia of inflam
mation, Nevertheless, the high levels of loosely-bound iron found afte
r Fe-dextran treatment in plasma and in exudate contribute to the incr
ease in oxidative stress. Dfx treatment had no effect on anemia or on
lipid peroxidation.